These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 6361672
1. [Anatomopathology of breast cancer and hormone receptors]. Contesso G, Delarue JC, Mouriesse H, May-Levin F, Garnier H. Pathol Biol (Paris); 1983 Nov; 31(9):747-54. PubMed ID: 6361672 [Abstract] [Full Text] [Related]
2. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients. Blanco G, Alavaikko M, Ojala A, Collan Y, Heikkinen M, Hietanen T, Aine R, Taskinen PJ. Anticancer Res; 1984 Nov; 4(6):383-9. PubMed ID: 6097159 [Abstract] [Full Text] [Related]
3. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P. Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760 [Abstract] [Full Text] [Related]
4. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Thike AA, Chng MJ, Fook-Chong S, Tan PH. Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603 [Abstract] [Full Text] [Related]
5. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA, Mamoon N, Mushtaq S, Khadim MT. J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [Abstract] [Full Text] [Related]
6. Relationships of steroid hormone receptors, age and histological characteristics in human breast cancer. Mureşan Z, Duţu R, Voiculetz N. Neoplasma; 1986 Feb; 33(3):371-7. PubMed ID: 3016577 [Abstract] [Full Text] [Related]
7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228 [Abstract] [Full Text] [Related]
8. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression. Maiorana A, Cavallari V, Bagni A, Ussia F, Maiorana MC, Fano RA. Anal Cell Pathol; 1996 Aug 01; 11(3):199-209. PubMed ID: 8888955 [Abstract] [Full Text] [Related]
9. [Steroid hormone receptors and survival in breast cancer patients]. Ivanova OA, Tsyrlina EV, Moiseenko VM, Semiglazov VF. Vopr Onkol; 1986 Aug 01; 32(6):71-6. PubMed ID: 3727485 [Abstract] [Full Text] [Related]
11. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. Lertsanguansinchai P, Chottetanaprasith T, Chatamra K, Sampatanukul P, Wannakrairot P, Rojpornpradit P, Shotelersuk K, Lertbutsayanukul C, Boonjunwetwat D, Vajragupta L. J Med Assoc Thai; 2002 Jun 01; 85 Suppl 1():S193-202. PubMed ID: 12188412 [Abstract] [Full Text] [Related]
12. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Biesterfeld S, Schröder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, Handt S, Böcking A. Anticancer Res; 1997 Jun 01; 17(6D):4723-9. PubMed ID: 9494596 [Abstract] [Full Text] [Related]
13. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay. Cavaliere A, Bucciarelli E, Sidoni A, Bianchi G, Pietropaoli N, Ludovini V, Vitali R. Cytometry; 1996 Sep 15; 26(3):204-8. PubMed ID: 8889392 [Abstract] [Full Text] [Related]
14. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P. Breast J; 2005 Sep 15; 11(4):278-80. PubMed ID: 15982396 [Abstract] [Full Text] [Related]
15. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors]. Ellinidi VN, Anikseeva NV, Goncharova OA, Krasnozhon DA, Fedorov KA. Vopr Onkol; 2004 Sep 15; 50(2):234-6. PubMed ID: 15176229 [Abstract] [Full Text] [Related]
16. A multifactorial analysis of different biological and clinical parameters in breast cancer. Toma S, Coialbu T, Bonassi S, Nicolò G, Rosso R. Anticancer Res; 1987 Sep 15; 7(3 Pt B):401-7. PubMed ID: 3631893 [Abstract] [Full Text] [Related]
17. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA. Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477 [Abstract] [Full Text] [Related]
18. Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome. Glaubitz LC, Bowen JH, Cox EB, McCarty KS. Arch Pathol Lab Med; 1984 Jan 01; 108(1):27-30. PubMed ID: 6546333 [Abstract] [Full Text] [Related]